Pag-aaral pangklinika para sa Alopecia sa New York
7 pag-aaral para sa Alopecia ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Montefiore Medical Center, The Bronx
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05723198Phase 2/3 Efficacy and Safety of PP405 in Adult Males
- The Skin Center Dermatology Group, New City
- Marc Avram, MD Office, New York
- Equity Medical, LLC, New York
- at 2 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 55 · Kalalakihan · Na-update Okt 28, 2026 · NCT07819435A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06873945Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
- Montefiore Medical Center, The Bronx
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT052139361470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
- Montefiore Einstein Advanced Care, Elmsford
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05460611Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
- UnionDerm, New York
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 55 · Lahat ng kasarian · Na-update Ene 2, 2026 · NCT06885112Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
- Montefiore Einstein Advanced Care, Elmsford
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06946550Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.